Correlation Between Sellas Life and ProQR Therapeutics
Can any of the company-specific risk be diversified away by investing in both Sellas Life and ProQR Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sellas Life and ProQR Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sellas Life Sciences and ProQR Therapeutics BV, you can compare the effects of market volatilities on Sellas Life and ProQR Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sellas Life with a short position of ProQR Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sellas Life and ProQR Therapeutics.
Diversification Opportunities for Sellas Life and ProQR Therapeutics
-0.28 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Sellas and ProQR is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Sellas Life Sciences and ProQR Therapeutics BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProQR Therapeutics and Sellas Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sellas Life Sciences are associated (or correlated) with ProQR Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProQR Therapeutics has no effect on the direction of Sellas Life i.e., Sellas Life and ProQR Therapeutics go up and down completely randomly.
Pair Corralation between Sellas Life and ProQR Therapeutics
Considering the 90-day investment horizon Sellas Life Sciences is expected to under-perform the ProQR Therapeutics. In addition to that, Sellas Life is 1.03 times more volatile than ProQR Therapeutics BV. It trades about -0.05 of its total potential returns per unit of risk. ProQR Therapeutics BV is currently generating about 0.08 per unit of volatility. If you would invest 350.00 in ProQR Therapeutics BV on September 1, 2024 and sell it today you would earn a total of 17.00 from holding ProQR Therapeutics BV or generate 4.86% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sellas Life Sciences vs. ProQR Therapeutics BV
Performance |
| Timeline |
| Sellas Life Sciences |
| ProQR Therapeutics |
Sellas Life and ProQR Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sellas Life and ProQR Therapeutics
The main advantage of trading using opposite Sellas Life and ProQR Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sellas Life position performs unexpectedly, ProQR Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProQR Therapeutics will offset losses from the drop in ProQR Therapeutics' long position.| Sellas Life vs. Tff Pharmaceuticals | Sellas Life vs. Eliem Therapeutics | Sellas Life vs. Inhibrx | Sellas Life vs. Enliven Therapeutics |
| ProQR Therapeutics vs. Annexon | ProQR Therapeutics vs. Arrowhead Pharmaceuticals | ProQR Therapeutics vs. Day One Biopharmaceuticals | ProQR Therapeutics vs. Terns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |